GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and tirzepatide (Mounjaro, Zepbound) are FDA-approved for type 2 diabetes and obesity management
For example, medications like ACE inhibitors , ARBs , and beta-blockers generally do not interfere with the cardiovascular benefits of GLP-1 therapies
Provide patients with simple instructions: hold the dose the day before, check glucose more often, and bring their medication list to the hospital
Altern Med Rev
this eases the storage and disposal since each pen is disposed of after one injection
Instead, inject a single dose as soon as you remember and adjust your schedule accordingly